| scholarly article | Q13442814 |
| P2093 | author name string | Sandeep Mahajan | |
| Arun Kumar Subbiah | |||
| Yogesh K Chhabra | |||
| P2860 | cites work | Antiplatelet agents for chronic kidney disease | Q24200752 |
| Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease | Q24235834 | ||
| Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction | Q28196824 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
| Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease | Q30407860 | ||
| Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 | ||
| Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study | Q34765857 | ||
| Cardiac troponins in renal insufficiency: review and clinical implications | Q35035403 | ||
| Cardiovascular risk in chronic kidney disease | Q35918609 | ||
| Use of cardiac biomarkers in end-stage renal disease | Q37102909 | ||
| Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease | Q37282300 | ||
| Coronary artery disease in patients with chronic kidney disease: a clinical update | Q37614917 | ||
| Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis | Q37925218 | ||
| Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant | Q38023320 | ||
| Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease | Q38072361 | ||
| Chronic kidney disease as a coronary artery disease risk equivalent | Q38075813 | ||
| Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention | Q38111136 | ||
| Cardiorenal syndrome--current understanding and future perspectives | Q38163817 | ||
| Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. | Q38238842 | ||
| Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review | Q38376813 | ||
| The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial | Q40204908 | ||
| Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis | Q40609414 | ||
| Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? | Q43519854 | ||
| Level of kidney function as a risk factor for cardiovascular outcomes in the elderly | Q44358496 | ||
| Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. | Q44545666 | ||
| Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. | Q44794443 | ||
| The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. | Q44846799 | ||
| Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease | Q46460979 | ||
| Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates | Q46609102 | ||
| Optimal strategy of coronary revascularization in chronic kidney disease patients: a meta-analysis | Q46868898 | ||
| The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population | Q46963308 | ||
| Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation | Q47760954 | ||
| Cardiovascular disease and subsequent kidney disease | Q50155784 | ||
| Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. | Q51800530 | ||
| Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). | Q53150011 | ||
| Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure | Q67522122 | ||
| Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods | Q71809457 | ||
| ACE inhibitors and survival of hemodialysis patients | Q78450239 | ||
| Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts | Q83393056 | ||
| P433 | issue | 2 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 56-61 | |
| P577 | publication date | 2016-11-07 | |
| P1433 | published in | Heart Asia | Q27723622 |
| P1476 | title | Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup | |
| P478 | volume | 8 |
| Q93145972 | Carotid Intima-Media Thickness: A Surrogate Marker for Cardiovascular Disease in Chronic Kidney Disease Patients |
| Q89545116 | Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? |
| Q91928418 | Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease |
| Q37373437 | High Burden of Unrecognized Atrial Fibrillation in Rural India: An Innovative Community-Based Cross-Sectional Screening Program |
| Q90434493 | Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD |
| Q92358968 | Risky Business: Judging the Use of Non-Vitamin K Antagonist Oral Anticoagulants for Non-Valvular Atrial Fibrillation in Patients with Renal Dysfunction |
| Q92811508 | The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease |
Search more.